HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA 2005 Action Plan Aims To Reinforce Industry Credibility

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic, Toiletry and Fragrance Association is implementing a multi-pronged action plan in 2005 to address cosmetic safety concerns and reinforce the industry's credibility with consumers

You may also be interested in...



CTFA Appoints State Legislator Hurson To Government Affairs Team

The Cosmetic, Toiletry and Fragrance Association has appointed former Maryland General Assembly Majority Leader and current Chairman of the Health and Government Operations Committee John Hurson to the post of VP of government affairs

CTFA Appoints State Legislator Hurson To Government Affairs Team

The Cosmetic, Toiletry and Fragrance Association has appointed former Maryland General Assembly Majority Leader and current Chairman of the Health and Government Operations Committee John Hurson to the post of VP of government affairs

CIR meets with Crawford

Cosmetic Ingredient Review provides FDA a list of 132 ingredients with insufficient safety data during its first meeting with FDA Acting Commissioner Lester Crawford, CIR Director Alan Andersen, PhD, reports during panel's June 13-14 meeting in Washington, D.C. Sitdown, which occurred April 25, is part of a new credibility action plan developed by the Cosmetic, Toiletry and Fragrance Association (1"The Rose Sheet" March 14, 2005, p. 3). CIR is seeking to encourage FDA to "implement its available regulatory authority to require warning labels or suggest to companies that warning labels may be required...as a way to encourage the industry to provide the data to fill the...gaps that the panel has identified," Anderson notes...

Related Content

Latest News
See All
UsernamePublicRestriction

Register

RS012888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel